KSMModel.ai says healthcare AI visibility score rose 50 points in 30 days

KSMModel.ai released Day 30 results from its 90-day study with Bayside, Queens practice PeptideDoc, saying the organization’s AI visibility score climbed to 85 out of 100 from a 35-point baseline. The company says the findings show how digital structure, entity recognition and outside corroboration can help AI systems better understand and connect an organization.

Why it matters: - The study is designed to show how organizations can improve the way search engines and AI systems interpret who they are, where they are, and what they do. - The findings matter for healthcare groups because digital identity can affect discoverability across search, answer engines and generative AI tools. - KSMModel.ai says the Day 30 results show a shift from basic machine readability to stronger external corroboration.

What happened: - KSMModel.ai released Day 30 findings from its ongoing 90-day healthcare AI visibility study on Nov. 3, 2026. - The study centers on PeptideDoc, a physician-led medical practice in Bayside, Queens, New York. - PeptideDoc started with a pre-launch KSM score of 35/100. - The score rose to 62/100 on Day 1 after the initial implementation phase. - By Day 30, PeptideDoc reached 85/100, a 50-point gain from baseline and a 23-point gain from Day 1. - Dr. Anthony Q. Bowen, founder of KSMModel.ai, said the Day 30 release is a continuation of the October launch, not a separate assessment.

The details: - The Knowledge Structuring Model, or KSM, measures AI Visibility across three weighted dimensions. - Structured Extractability carries a 40% weight and measures whether machines can reliably retrieve and interpret key organizational information. - Entity Salience carries a 40% weight and measures whether search and AI systems can connect an organization with its leadership, location, services, credentials and authoritative profiles. - Citation Authority carries a 20% weight and measures whether independent external sources corroborate those relationships. - At Day 30, PeptideDoc scored 36/40 for Structured Extractability, 34/40 for Entity Salience and 15/20 for Citation Authority. - The pre-launch scores were 16/40, 14/40 and 5/20, respectively. - The Day 1 scores were 30/40, 24/40 and 8/20, respectively. - The Day 1 score remains frozen at 62/100 under the study’s longitudinal methodology. - Changes made after Day 1 were measured only in the Day 30 checkpoint. - The first phase of implementation focused on canonical relationships, indexing signals, structured information, organizational identifiers, physician identity, location data, service relationships and machine-readable markup. - KSMModel.ai says the later phase examined whether external sources could independently reinforce the same organizational relationships. - Those outside signals included business profiles, physician directories, professional platforms, credential references, third-party profiles and media coverage. - Citation Authority rose from 5/20 at pre-launch to 15/20 at Day 30. - KSMModel.ai says that increase shows external corroboration became a more important part of the overall AI Visibility profile. - Bowen said the study’s core question evolved from whether AI systems could understand the organization, to whether they could recognize the core entities, and then to whether outside sources could corroborate those relationships. - The progression is framed as Understand, Recognize, Corroborate. - Within KSM, the same progression is Structured Extractability, Entity Salience and Citation Authority.

Between the lines: - The study suggests AI visibility is not just about on-page optimization. - It also depends on whether the broader web presents a consistent, corroborated version of an organization’s identity. - Healthcare is a useful test case because a practice can be identified through multiple linked signals, including physicians, location, credentials, services and third-party references. - The report does not assess medical treatment or clinical outcomes. - It evaluates digital structure, entity recognition and external authority.

What's next: - KSMModel.ai says the 90-day study will continue toward its next checkpoints. - The company says the full case-study progression is available in its online client page: the full case study progression - KSMModel.ai describes itself as a research and advisory firm focused on AI Visibility, Answer Engine Optimization, Generative Engine Optimization and organizational knowledge structure. - PeptideDoc remains the healthcare implementation in the 90-day case study.

The bottom line: - KSMModel.ai says the biggest gain came not just from making PeptideDoc easier for AI systems to read, but from making its identity easier for outside sources to confirm.